Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

Takeda appoints new financial head

François-Xavier Roger brings experience from Sanofi and in telecoms

- PMLiVE

Claire Grindal moves from Munro and Forster to Red Door

Joins the Creston Health company as associate director

- PMLiVE

Setback for GSK as melanoma vaccine misses targets

Cancer immunotherapy disappoints in phase III

- PMLiVE

FDA grants priority review to Takeda’s colitis drug

Accelerates review time for vedolizumab

Novartis building

Novartis signs cell therapy deal with Regenerex

Involves platform that could allow transplant patients to live without lifelong immunosuppression

National Institute for Health and Care Excellence NICE logo

NICE questions cost of medicines development

Says pharma should determine if R&D spending of £1bn+ per drug is really necessary

- PMLiVE

New UK business unit head for Fishawack

Gary Lyons will lead the Fishawack Communications delivery team

- PMLiVE

Former Quintiles president Jeff Thomis to chair Idis

Will oversee company’s activities to develop managed access programmes for medicines

- PMLiVE

Otsuka to buy cancer biopharma Astex

Takes control of company behind Dacogen in $886m deal

- PMLiVE

Isis rises on positive triglyceride drug data

ISIS-APOCIII Rx can cause triglycerides to drop 75 per cent

- PMLiVE

J&J files rare blood disorder drug siltuximab in US and EU

Orphan drug to be assessed for use in the treatment of multicentric Castleman disease

Anthony Zook resigns as Vivus CEO

Replaced by former J&J executive Seth Fischer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links